Economie evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: Randomised trial

British Journal of Psychiatry

Volumn 196, Issue 4, 2010, Pages 310-318

  Gerhards, S A H ^a   De Graaf, L E ^a,b   Jacobs, L E ^a   Severens, J L ^a,c   Huibers, M J H ^a   Arntz, A ^a   Riper, H ^d,e   Widdershoven, G ^a,f   Metsemakers, J F M ^a   Evers, S M A A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; UNCERTAINTY; ADOLESCENT; COMPUTER ASSISTED THERAPY; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; MIDDLE AGED; NETHERLANDS; PRIMARY HEALTH CARE; PSYCHOLOGICAL RATING SCALE; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; NETHERLANDS; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950683819     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.065748     Document Type: Article

References (40)

1. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587-595 (Pubitemid 28528860)
2. Bijl RV, Ravelli A. Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2000; 30: 657-668 (Pubitemid 30410328)
3. Kruijshaar ME, Hoeymans N, Bijl RV, Spijker J, Essink-Bot ML. Levels of disability In major depression. Findings from the Netherlands Mental Health Survey and incidence Study (NEMESIS). J Affect Disord 2003; 77: 53-64. (Pubitemid 37205151)
4. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87-98.
5. Kendrick T, Chatwin J, Dowrick C, Tuylee A, Moriss R, Peveler R, et al. Randomised controlled trial to determine the clinical effectiveness and costeffectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study. Health Technol Assess 2009; 13: 1-159.
6. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006; 26: 17-31.
7. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol 2006; 57: 285-315. (Pubitemid 43237234)
8. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997; 277: 333-340 (Pubitemid 27045015)
9. Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverly C, et al. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess 2006; 10: 1-186.
10. National institute for Health and Clinical Excellence. Computerised Cognitive Behaviour Therapy for Depression and Anxiety. Review of Technology Appraisal 51. NICE, 2006.
11. McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, et al. Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 2004; 185: 55-62. (Pubitemid 38951630)
12. de Graaf LE, Gerhards SAH, Arntz A, Riper H, Metsemakers JFM, Evers SMAA, et al. Clinical effectiveness of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Sr J Psychiatry 2009; 195: 73-80.
13. van der Does AJW. De Nederlandse versle van de Beck Depression inventory - second edition (BDl-Il-NL): Handleiding (in Dutch) [The Dutch Version of the Beck Depression Inventory - Second Edition (BDl-Il-NL): A Manual]. The psychological Corporation, 2002.
14. de Graaf LE, Gerhards SAH, Evers SMAA, Arntz AR, Riper H, Severens JL, et al. Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial. BMC Public Health 2008; 8: 224. (Pubitemid 352019970)
15. CBO. Multidisciplinair Richtlijn Depressie: Richtlijn voor de Dlagnostiek en Behandeling van volwassen Cliedie;nten met een Depressie [Multidisciplinary Guideline Depression: Guideline for Diagnostics and Treatment of Adult Depression Clients]. Trimbos-instituut, 2005.
16. Nederlands Huisartsen Genootschap. NHG-Standaard Depressieve Stoornis (Depressie) [Dutch College of General Practitioners - Practice guidelines depressive disorder (depression)]. Nederlands Huisartsen Genootschap, 2003.
17. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2005.
18. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor Kostenonderzoek: Methoden enStandaard Kostprijzen voor Economische Evaluates in de Gezondheidszorg (Geactualiseerde versie 2004) [Dutch Manual for Costing: Methods and Standard Costs for Economic Evaluations in Health Care (actualized version 2004)]. College voor zorgverzekeringen, 2004.
19. Koopmanschap M, Meerding WJ, Evers S, Severens J, Burdorf A, Brouwer W. Handleiding voor het gebruik van PRODISQ versie 2.1 [Manual for the Use of PRODISQ version 2.1]. Erasmus MC - lnstituut voor Medical Technology Assessment, instituut Maatschappelijke Gezondheidszorg, Universiteit van Maastricht - Beleid Economie en Organlsatie van de zorg, 2004.
20. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method for estimating the indirect costs of disease. J Health Econ 1995; 14: 171-189
21. College voor zorgverzekeringen. Farmacotherapeutisch Kompas 2008 [Pharmacotherapeutic Compass 2008]. College voor Zorgverzekeringen, 2007.
22. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597 (Pubitemid 26382973)
23. Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression inventory-II with primary care medical patients. Health Psychol 2001; 20: 112-119 (Pubitemid 32233867)
24. EuroQol Group. EuroQol - a new facility for the measurement of healthrelated quality of life. Health Policy 1990; 16: 199-208.
25. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1115-1128 (Pubitemid 28527167)
26. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108 (Pubitemid 127453463)
27. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006; 15:1121-1132 (Pubitemid 44596379)
28. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21: 271-292 (Pubitemid 34143147)
29. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42: 851-859 (Pubitemid 39456916)
30. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6: 405-415
31. van Asselt ADI, van Mastrigt GAPG, Dirksen CD, Arntz A, Severens JL, Kessels AGH. How to deal with cost differences at baseline. Pharmacoeconomics 2009; 27: 519-528
32. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYS in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487-496 (Pubitemid 40723857)
33. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change In psychotherapy research. J Consult Clin Psychol 1991; 59: 12-19
34. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998; 20: S68-80. (Pubitemid 28175944)
35. Fenwick E, O'Brien BJ, Briggs A. Economic evaluation. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004; 13: 405-415 (Pubitemid 38660390)
36. Raad voor de Volksgezondheid en Zorg. Zinnige en Duurzame Zorg [Sensible and Sustainable Care]. Zoetermeer, 2006.
37. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression. Arch Gen Psychiatry 2004; 61: 714-719
38. Friedman MA, Detweiler-Bedell JB, Leventhal HE, Horne R, Keitner Gi, Miller IW. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract 2004; 11: 47-68. (Pubitemid 38735568)
39. van den Brink M, van den Hout WB, Stiggelbout AM, van de Velde CJH, Kievlt J. Cost measurement in economic evaluations of health care. Whom to ask? Med Care 2004; 42: 740-746
40. Vuorllehto M, Melartln TK, Rytsälä HJ, Isometsä E. Do characteristics of patients with major depressive disorder differ between primary and psychiatrie care? Psychol Med 2007; 37: 893-904. (Pubitemid 46746333)